Find in Library

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

oleh: Ke Wang, Feng Zhang, Hui Zhang, Jie Zhao, Chen Wu, Ping Wang, Xiaofeng Wu, Feipeng Zhu, Xiaofeng Qian, Yongxiang Xia, Xuehao Wang, Xiangcheng Li, Hanyuan Liu, Lang Qin, Si Li, Feng Cheng, Xiangyi Kong, Weiwei Tang, Chuanyong Zhang, Donghua Li, Jinhua Song, Aihua Yao, Guwei Ji, Xisheng Liu, Xuan Xiao, Zhenhua Deng, Yangyang Yu, Wenjing Xi, Wanglong Deng, Chuang Qi, Liyong Pu